Walgreens Boots Alliance is taking full control of CareCentrix, acquiring the 45% not already owned in the post-acute care manager for approximately $392 million, the pharmacy chain said Tuesday.
Why it matters: As rivals dominate headlines with aggressive M&A, WBA has been accelerating its existing efforts. Perhaps just a little more quietly, Sarah writes.
